How would you feel if your local GP or specialist was pocketing money from a drug company to promote its products? If your gut tells you that this falls squarely into the category of Very Bad Ideas then…
Academic rigour, journalistic flair
Articles on Big Pharma
Displaying 101 - 111 of 111 articles
The 2008 global financial crisis and an impending “patent cliff” have had a profound impact on the profitability of the pharmaceutical industry – they have made it change how it works. So, to maintain…
Many pharmaceutical companies are having to re-examine their product portfolio because of the difficult economic climate. New uses for established drugs affords a way for these companies to maximise financial…
It’s the pharmaceutical industry equivalent of the butterfly effect: a drug manufacturing plant in Ohio shuts down production after regulators on two continents uncover contamination problems. Suddenly…
The enormous medical impact of modern pharmaceuticals has on occasion been matched by some large-scale litigation regarding adverse events. The Vioxx litigation in Australia and elsewhere is one such recent…
First it was the Pharmacy Guild’s deal with Blackmores that raised ethical concerns. Now it’s the Guild and Pfizer. Both deals involve undisclosed payments from drug companies to Guild subsidiaries to…
Welcome to “The most powerful companies you’ve never heard of” – an ongoing series from The Conversation that sheds light on big companies with low profiles. Today, Deakin University’s Philip Soos examines…
This week Radio National’s Background Briefing looks at how pharmaceutical companies market their products to doctors. The program is presented by Ray Moynihan, an award-winning journalist, columnist at…
“Would you like the generic brand of that medicine?” It’s a question you’ve probably been asked, or at least heard, when picking up a prescription at your local pharmacy. It’s likely you were told the…
Any parent who watches kids’ weekend footy knows that if the ref misses a breach of the rules, merry hell breaks loose. But referees are human and sometimes make errors. We forgive the odd one pretty quickly…
The US Court of Appeals for the Federal Circuit has found Myriad Genetics is entitled to patents on two sets human genetic mutations used to predict if women have an increased risk of breast and ovarian…
Job Board
-
Program Manager, Teaching & Learning Initiatives
-
Lecturer/Senior Lecturer, Earth System Science (School of Science)
-
Sydney Horizon Educators (Identified)
-
Deputy Social Media Producer
-
Associate Professor, Occupational Therapy
Top contributors
-
Joel Lexchin is a Friend of The Conversation.Professor Emeritus of Health Policy and Management, York University, Canada
-
Assistant Professor, Bond University
-
Professor of Bioethics, Macquarie University
-
Associate Professor, School of Law, University of Canberra
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Chief Scientist, Center for Bioethics and Humanities and Professor of Medicine and Public Health, University of Colorado Anschutz Medical Campus
-
Lecturer in Accounting & Management, Lancaster University
-
Associate Professor Politics and Policy Studies, Deakin University
-
Health activist, Medreach Pty Ltd., Bond University
-
Macquarie University Research Fellow, Macquarie University
-
HERA Program Director - Health Workforce Optimisation Centre for the Business & Economics of Health, The University of Queensland
-
PhD Candidate, Swinburne University of Technology
-
Associate professor, University of Sydney
-
Adjunct Professor, Australian Centre for Health Law Research, School of Law, Queensland University of Technology
-
Dean, University of Wollongong
